OBJECTIVE: To investigate the capability of human placenta-derived adherent cells to differentiate into osteocytes and adipocytes. METHODS: Placenta-derived adherent cells were isolated by type IV collagenase digestion of a single freshly obtained human placenta and cultured under standard conditions. Cell surface markers of adherent cells from passages 3 -9 were analysed by flow cytometry. Osteocytic differentiation was induced with b-glycerol phosphate, vitamin C and dexamethasone and confirmed by Alizarin red staining. Adipocytic differentiation was induced with dexamethasone and insulin and confirmed by oil red O staining. RESULTS: Placenta-derived adherent cells were positive for high levels of CD44 and CD105 and very low levels of CD29 but were negative for CD34, CD45 and CD19. This pattern of cell surface markers is identical to human mesenchymal stem cells. Alizarin red-positive cells were detected 10 days after the induction of osteocyte differentiation. Oil red O-positive cells were detected 7 days after the induction of adipocyte differentiation. CONCLUSIONS: Placenta-derived adherent cells can differentiate into either osteocytes or adipocytes in vitro. The human placenta may provide an alternative source of mesenchymal stem cells for basic research and clinical use.
Introduction
Mesenchymal stem cells have multiple differentiation capabilities and self-renewal potential, and are promising as possible therapeutic agents for the treatment of many human diseases, such as type 2 diabetes. 1, 2 In the past, bone marrow cells have been the major source of mesenchymal stem cells, 2 -4 but their numbers are limited by ageing, infectious disease or tumours. 5, 6 The identification of alternative sources of human mesenchymal stem cells is necessary for basic research and clinical use. Studies have provided evidence for the presence of mesenchymal stem cells in human placental tissue, 6 but their isolation procedure, biological characteristics and differentiation capabilities have not been well defined. 
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The present study developed a collagenase-based digestion strategy for the isolation of placenta-derived adherent cells. The cell surface markers and differentiation capability of these cells were examined in order to determine whether they were mesenchymal stem cells.
Materials and methods

PLACENTAL CELL ISOLATION AND CULTURE
A single fresh human placenta from a fullterm caesarean section was obtained from the Department of Obstetrics and Gynaecology, Qilu Hospital of Shandong University, in August 2009. The study was approved by the Ethics Committee of Qilu Hospital of Shandong University (reference number , and the donor provided verbal informed consent.
The internal sections of the central placenta lobules were dissected, washed extensively with ice-cold 20 mM phosphate-buffered saline (PBS), pH 7.2, minced and incubated with 5 g/l type IV collagenase (Sigma-Aldrich, St Louis, MO, USA) in serum-free Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Gaithersburg, MD, USA) for 30 min at 37°C. The resulting cell suspension was centrifuged at 177 g for 5 min, and the pellet was redigested as above to yield a single cell suspension. Cells were cultured at a density of 10 4 cells/ml in DMEM supplemented with 10% fetal bovine serum (Gibco BRL), 100 U penicillin, 100 mg/ml streptomycin and 50 mg/ml L-glutamine (complete medium) at 37°C in a humidified atmosphere containing 5% carbon dioxide. Culture medium and nonadherent cells were removed and replaced with fresh culture medium (half the volume of the removed medium) every 3 -5 days. Adherent cells were trypsinized after 14 days of culture and split at a ratio of 1 : 3; nonadherent cells were removed before trypsinization. The following experiments used placenta-derived adherent cells from passages 3 -9 of cell culture. These cells formed a homogeneous population, as monitored by flow cytometry. Not every culture was assessed by flow cytometry prior to its use in other experiments.
FLOW CYTOMETRY ANALYSIS
Single-cell suspensions of placenta-derived adherent cells were prepared by treatment with 1% ethylenediaminetetra-acetic acid (Invitrogen Corp., Carlsbad, CA, USA) for 3 min at 37°C. The reaction was terminated by adding complete medium and the cells were collected by centrifugation at 177 g for 5 min. Cells were washed twice with ice-cold 20 mM PBS, pH 7.2, resuspended at 10 6 cells/100 µl in 20 mM PBS and stained with fluorescein isothiocyanate-or phycoerythrin-conjugated monoclonal antihuman CD19, CD29, CD44, CD45, CD34 or CD105 antibodies (Jingmei Biotech Co. Ltd, Shenzhen, China) at 37°C for 30 min. The cells were washed three times with 20 mM PBS, fixed in 4% paraformaldehyde (Runjie Biology Co., Shanghai, China) and analysed by flow cytometry (Beckman Coulter, Brea, CA, USA).
OSTEOCYTIC DIFFERENTIATION
Placenta-derived adherent cells were trypsinized, washed with 20 mM PBS, pH 7.2, and resuspended in complete medium as described earlier. Cells were plated into sixwell plates at 10 5 cells/well in the presence of osteocytogenic reagents (20 mM β-glycerol phosphate, 50 µg/ml vitamin C and 10 mM dexamethasone) for 10 days. The culture medium was replaced every 3 -5 days. Parallel control cells were cultured without osteocytogenic reagents.
ADIPOCYTIC DIFFERENTIATION
Placenta-derived adherent cells were plated NZ Sun, HS Ji Human placenta-derived adherent cells in six-well plates as described above. Adipocytic differentiation was induced by treatment with 10 mM dexamethasone and 10 mg/l insulin for 7 days. The culture medium was replaced every 3 -5 days. Parallel control cells were cultured without adipocytogenic reagents.
ALIZARIN RED STAINING
Alizarin red staining was performed using a standard protocol as described previously. 7 At 10 days after the induction of osteocytic differentiation, cells were fixed in acetone for 30 min at 37°C and washed three times with 20 mM PBS, pH 7.2. Cells were stained with Alizarin red solution (1%, pH 8.3) at 37°C for 8 h and nonspecific staining was removed by washing three times with 20 mM PBS, pH 7.2. Cells were visualized via inverted light microscopy and photographed. These experiments were repeated three times with cultured cells from the same placenta.
OIL RED O STAINING
Oil red O staining was performed as described previously. 8 Seven days after treatment with adipocytogenic agents, cells were fixed in acetone for 30 min at 37°C and washed three times with 20 mM PBS, pH 7.2, followed by incubation with oil red O solution (0.3%) for 30 min at 37°C. Nonspecific staining was removed by washing three times with isopropanol. Cells were visualized via inverted light microscopy and photographed. These experiments were repeated three times with cultured cells from the same placenta.
Results
Adherent cells from digested placental tissue were observed after about 1 -2 weeks in culture. These cells were morphologically irregular (Fig. 1) , and began to resemble colony forming fibroblast-like cells after 4 weeks. Cells were passaged weekly and could be maintained for around 10 passages. 
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Flow cytometry analysis indicated that placenta-derived adherent cells were positive for high levels of CD44 (98.8%) and CD105 (67.4%). Very low levels of CD29 staining were observed, but no CD34, CD45 or CD19 staining was detected (Fig. 2) .
Alizarin red-positive osteocyte-like cells (about 8% of total cells) were observed 10 days after incubation with osteocytogenic agents (Fig. 3A ). There were no Alizarin red-positive cells present in control cultures (Fig. 3B) .
Culture of placenta-derived adherent cells in the presence of dexamethasone and insulin resulted in some (about 4%) cells staining positive with oil red O (Fig. 4A ). There were no oil red O-positive cells present in control cultures ( Fig 4B) .
Discussion
Placenta-derived adherent cells were successfully isolated in the present study. In vitro differentiation experiments indicated that these cells had bidirectional differentiation potential. The pluripotent nature of human mesenchymal stem cells has led to them being extensively investigated, 9 -13 particularly in terms of their potential use in regenerative medicine. 14 -16 There are currently no standard protocols available for the isolation of mesenchymal stem cells, and specific markers have not been identified to characterize these stem cells or progenitors. Previous studies have indicated that mesenchymal stem cells are adherent fibroblast-like cells. 7, 8 They are generally defined as stem cells due to their pluripotency. 17 -20 A collagenase-based approach for the isolation of placentaderived adherent cells was developed in the present study.
Flow cytometry analysis revealed that the placenta-derived adherent cells in the present study were weakly positive for CD29, strongly positive for CD44 and CD105, but negative for CD34, CD45 and CD19, indicating that they were neither fibroblasts nor epithelial cells. 21 These cell surface markers are the same as those expressed by bone marrow stem cells, suggesting that the placenta-derived adherent cells isolated in the present study are similar to previously isolated mesenchymal stem cells. 22 -28 It is not possible to define these cells as mesenchymal stem cells based solely on morphological observations and cell surface phenotype without demonstration of their pluripotent differentiation capacity.
Placenta-derived adherent cells can differentiate into neuronal or chondroitic cells. 29, 30 It has been shown that mesenchymal stem cells are capable of differentiating into osteocytes in the presence of the same osteocytogenic reagents used in the present study. 7 Placenta-derived adherent cells were successfully differentiated into osteocyte-like cells in the present study, as shown by positive Alizarin red staining. Alizarin red specifically stains calcium deposits, demonstrating the accumulation of calcium in these osteocytelike cells. Oil red O staining confirmed the successful induction of adipocytic differentiation from the placenta-derived adherent cells in this culture system.
In conclusion, the present study demonstrated that human placenta-derived adherent cells have bidirectional differentiation capability and may provide an alternative source of mesenchymal stem cells for both basic research and clinical use.
